Inside the Laboratory: Grinias Research Lab at Rowan University, Part III – LC Demonstration
In this continuing series from LCGC, we go on location to the Grinias Research Lab at Rowan University to see a liquid chromatographic analyzer in action.
Welcome to this installment of "Inside the Laboratory" in which the LCGC editorial team leaves their New Jersey office and ventures out in the field, with the goal of giving our audience a window into the next generation of analytical chemists.
Rowan University in Glassboro, New Jersey, is home to the Grinias Research Lab headed by James Grinias, a professor in the department of Chemistry & Biochemistry. You can find the first two parts of our visit to the Grinias lab here:
Inside the Laboratory: Grinias Research Lab at Rowan University, Part I – Jim Grinias Interview
In the video below, Samuel Foster of the Grinias lab explains the mechanisms behind a liquid chromatography (LC) system and the software used to process LC analysis.
LCGC will be releasing further video interviews with Grinias’ students in the coming weeks.
Check back soon for more from Rowan University!
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
